Trial Details

COMPLETED
Basic Information
Clinical ID c4372
Identifier NCT00613197
Trial Title EPANOVA in Crohn's Disease, Study 1
Trial URL Visit Original Page
Study Information
Study Results

NO
Conditions Crohn's Disease
Interventions DRUG: Epanova
Participant Information
Sponsor Tillotts Pharma AG
City Leuven
Country/Region Belgium
Enrollment Criteria
Sex Requirement ALL
Age Requirement ADULT, OLDER_ADULT
Study Design
Study Type INTERVENTIONAL
Phase PHASE3
Time Information
Start Date 2003-01
Primary Completion Date 2006-08
Completion Date 2006-08